Literature DB >> 18700135

A multi-metabolite analysis of serum by 1H NMR spectroscopy: early systemic signs of Alzheimer's disease.

Taru Tukiainen1, Tuulia Tynkkynen, Ville-Petteri Mäkinen, Pasi Jylänki, Antti Kangas, Johanna Hokkanen, Aki Vehtari, Olli Gröhn, Merja Hallikainen, Hilkka Soininen, Miia Kivipelto, Per-Henrik Groop, Kimmo Kaski, Reino Laatikainen, Pasi Soininen, Tuula Pirttilä, Mika Ala-Korpela.   

Abstract

A three-molecular-window approach for (1)H NMR spectroscopy of serum is presented to obtain specific molecular data on lipoproteins, various low-molecular-weight metabolites, and individual lipid molecules together with their degree of (poly)(un)saturation. The multiple data were analysed with self-organising maps, illustrating the strength of the approach as a holistic metabonomics framework in solely data-driven metabolic phenotyping. We studied 180 serum samples of which 30% were related to mild cognitive impairment (MCI), a neuropsychological diagnosis with severely increased risk for Alzheimer's disease (AD). The results underline the association between MCI and the metabolic syndrome (MetS). Additionally, the low relativeamount of omega-3 fatty acids appears more indicative of MCI than low serum omega-3 or polyunsaturated fatty acid concentration as such. The analyses also feature the role of elevated glycoproteins in the risk for AD, supporting the view that coexistence of inflammation and the MetS forms a high risk condition for cognitive decline.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18700135     DOI: 10.1016/j.bbrc.2008.08.007

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  33 in total

1.  Characterization of metabolic interrelationships and in silico phenotyping of lipoprotein particles using self-organizing maps.

Authors:  Linda S Kumpula; Sanna M Mäkelä; Ville-Petteri Mäkinen; Anna Karjalainen; Johanna M Liinamaa; Kimmo Kaski; Markku J Savolainen; Minna L Hannuksela; Mika Ala-Korpela
Journal:  J Lipid Res       Date:  2009-09-05       Impact factor: 5.922

Review 2.  Metabolomics: a novel approach to identify potential diagnostic biomarkers and pathogenesis in Alzheimer's disease.

Authors:  Xu-Hua Xu; Yue Huang; Gang Wang; Sheng-Di Chen
Journal:  Neurosci Bull       Date:  2012-10-03       Impact factor: 5.203

3.  Evaluation of sample preparation protocols for quantitative NMR-based metabolomics.

Authors:  Olga A Snytnikova; Anastasiya A Khlichkina; Renad Z Sagdeev; Yuri P Tsentalovich
Journal:  Metabolomics       Date:  2019-05-24       Impact factor: 4.290

Review 4.  Quantitative in vivo neurochemical profiling in humans: where are we now?

Authors:  Jessica McKay; Ivan Tkáč
Journal:  Int J Epidemiol       Date:  2016-10-29       Impact factor: 7.196

5.  Application of 31P NMR spectroscopy and chemical derivatization for metabolite profiling of lipophilic compounds in human serum.

Authors:  M Aruni DeSilva; Narasimhamurthy Shanaiah; G A Nagana Gowda; Kellymar Rosa-Pérez; Bryan A Hanson; Daniel Raftery
Journal:  Magn Reson Chem       Date:  2009-12       Impact factor: 2.447

6.  Large-scale human metabolic phenotyping and molecular epidemiological studies via 1H NMR spectroscopy of urine: investigation of borate preservation.

Authors:  Leon M Smith; Anthony D Maher; Elizabeth J Want; Paul Elliott; Jeremiah Stamler; Geoffrey E Hawkes; Elaine Holmes; John C Lindon; Jeremy K Nicholson
Journal:  Anal Chem       Date:  2009-06-15       Impact factor: 6.986

7.  Mild cognitive impairment associates with concurrent decreases in serum cholesterol and cholesterol-related lipoprotein subclasses.

Authors:  T Tukiainen; P Jylänki; V P Mäkinen; O Gröhn; M Hallikainen; H Soininen; M Kivipelto; K Kaski; P H Groop; M J Savolainen; T Pirttilä; P Soininen; M Ala-Korpela
Journal:  J Nutr Health Aging       Date:  2012-07       Impact factor: 4.075

8.  Lipoprotein subclass metabolism in nonalcoholic steatohepatitis.

Authors:  Ville T Männistö; Marko Simonen; Pasi Soininen; Mika Tiainen; Antti J Kangas; Dorota Kaminska; Sari Venesmaa; Pirjo Käkelä; Vesa Kärjä; Helena Gylling; Mika Ala-Korpela; Jussi Pihlajamäki
Journal:  J Lipid Res       Date:  2014-10-24       Impact factor: 5.922

9.  Sphingomyelin is associated with kidney disease in type 1 diabetes (The FinnDiane Study).

Authors:  Ville-Petteri Mäkinen; Tuulia Tynkkynen; Pasi Soininen; Carol Forsblom; Tomi Peltola; Antti J Kangas; Per-Henrik Groop; Mika Ala-Korpela
Journal:  Metabolomics       Date:  2011-08-05       Impact factor: 4.290

10.  Association between serum fatty acids and lipoprotein subclass profile in healthy young adults: exploring common genetic and environmental factors.

Authors:  Aline Jelenkovic; Leonie H Bogl; Richard J Rose; Antti J Kangas; Pasi Soininen; Mika Ala-Korpela; Jaakko Kaprio; Karri Silventoinen
Journal:  Atherosclerosis       Date:  2014-01-21       Impact factor: 5.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.